|
Radiology HomeDepartment OverviewFacultyResidencyFellowshipsNeuroradiologyRochester CommunityLinks |
|
|
||||||||||
![]() |
![]() |
| Figure 1. Axial FSEIR: Enlarged bilateral parotid glands with hypointense cystic-like changes. | Figure 2. Axial T2W FSE: enlarged parotid glands containing T2 hyperintense globular collections of watery saliva. |
Discussion:
Sjogren’s syndrome is a systemic autoimmune
disorder of the exocrine glands that occurs either alone (referred
to as primary Sjogren’s syndrome) or with any of several connective
tissue diseases (referred to as secondary Sjogren’s syndrome).
Traditionally, the diagnosis is established when two or more of the
following clinical hallmarks are present: keratoconjunctivitis sicca,
xerostomia, and a connective tissue disease, which usually is rheumatoid
arthritis. The incidence of sicca complex in rheumatoid arthritis
is estimated to be 15-25%. Other connective tissue diseases associated
with secondary Sjogren’s syndrome are SLE, progressive systemic
sclerosis, polymyositis, poliarteritis nodosa, and mixed connective
tissue disease [1].
Sjogren’s syndrome is characterized by failure of exocrine glands
resulting in the so called sicca syndrome (dry eyes and mouth), parotid
gland enlargement, dental caries, and recurrent tracheobronchitis
[2].
In the earliest stages of Sjogren’s syndrome, CT and MRI of the involved glands are normal. As the disease progresses and the glands increase in size, on CT a honeycomb glandular appearance develops. This CT appearance, once thought to be diagnostic of Sjogren’s syndrome, is now known to be produced by other granulomatous diseases or chronic sialadenitis [1].
On MRI, globular collections of watery saliva can be seen in the parotid glands. This MR appearance is characteristic of Sjogren’s syndrome [1].
There are other immunologic disorders that are associated with salivary gland enlargement and which cause salivary dysfunction and a sicca syndrome . These include patients infected with HIV, human T-cell lymphotrophic virus type III (HTLV-3), sialosis, granulomatous-type diseases such as sarcoidosis, amyloidosis, primary biliary cirrhosis, and graft vs host disease [1].
References:
| |
||
©Copyright University of Rochester Medical Center, 1999-2006. Disclaimer. For questions or suggestions concerning the content of these pages, contact the URMC Webmaster.